700 patients reviewed: are minimally invasive tumor removals effective Long-Term?

NCT ID NCT07353346

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks back at 700 patients who had endoscopic treatment for gastrointestinal submucosal tumors at Xijing Hospital. Researchers want to know how often the tumors are completely removed, what complications occur, and whether the tumors come back over time. The goal is to provide clearer guidance for doctors choosing the best treatment approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

endoscopic procedures (EMR, ESE, STER, EFR)

What this could lead to

If successful, this could help doctors choose the best endoscopic method for removing gastrointestinal tumors, leading to more personalized care.

What could go wrong

This is a retrospective review, not a controlled trial, so results may be influenced by past record-keeping and patient selection. It cannot prove cause and effect.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL SUBMUCOSAL TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastrointestinal stromal tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.